Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.5 USD | +8.92% | +6.97% | +4.10% |
Apr. 18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
Apr. 10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.10% | 714M | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- ALXO Stock
- News ALX Oncology Holdings Inc.
- Piper Sandler Adjusts Price Target on ALX Oncology Holdings to $48 From $70, Reiterates Overweight Rating